Is Nu Skin Enterprises, Inc. overvalued or undervalued?

As of 7 August 2025, the valuation grade for Nu Skin Enterprises, Inc. has moved from risky to attractive. The company appears undervalued, as indicated by its P/E ratio of 4, which is significantly lower than the peer average of 5.47, and its EV to EBITDA ratio of 6.39 compared to the peer average of 8.64. Additionally, the Price to Book Value stands at 0.95, suggesting that the stock is trading below its book value.
In comparison to its peers, Nu Skin's return on equity (ROE) is notably high at 23.44%, which further supports its attractive valuation. The company has outperformed the S&P 500 in recent periods, with a year-to-date return of 78.81% compared to the S&P 500's 12.22%, and a one-year return of 68.31% against 17.14% for the index. This performance reinforces the notion that Nu Skin is undervalued relative to its strong financial metrics and market performance.